A Q2 2021 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.5B+23.2% YoY

Gross Profit

$817M53.6% margin

Operating Income

$288M18.9% margin

Net Income

$216M14.2% margin

EPS (Diluted)

$0.70

QoQ Revenue Growth

-1.5%

Cash Flow

Operating Cash Flow

$472M

Free Cash Flow

$441M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$10.4B

Total Liabilities

$5.6B

Stockholders' Equity

$4.8B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.2B	+23.2%
Gross Profit	$817M	$657M	+24.4%
Operating Income	$288M	$102M	+182.4%
Net Income	$216M	$101M	+113.9%

Revenue Segments

Life Sciences and Applied Markets

$674M44%

Agilent CrossLab

$536M35%

Diagnostics and Genomics

$315M21%

Geographic Segments

Americas

$581M38%

Asia Pacific

$529M35%

Europe

$415M27%